Mangaluru: Cong workers say ‘Kumaraswamy ki jai’; JD(S) activists says ‘Sonia Gandhi ki jai’

New Delhi, Jun 25: The Central government submitted before the Supreme Court on Thursday that the remaining class 10 and 12 CBSE exams, which were earlier rescheduled to be held between July 1 to July 15 in view of the COVID-19 pandemic, have been cancelled.

Solicitor General Tushar Mehta, appearing for the Centre and Central Board of Secondary Education (CBSE), informed a three-judge bench headed by Justice AM Khanwilkar that the remaining class 10 and 12 CBSE exams scheduled to be held in July have been cancelled.

Delhi, Maharashtra, and Tamil Nadu have conveyed their inability to conduct the examinations, Mehta said.

The bench asked whether class 12 students were being given the option to either get marks on the internal assessment basis or appear for an exam later, to which the Mehta responded in the affirmative.

CBSE exams for class 10 students stand cancelled, Mehta said and added that they don't have to give any examinations. Mehta further submitted that as soon as conditions are conducive, CBSE exams for class 12 students, who opt for it, will be conducted.

The apex court was hearing a petition, filed by advocate Rishi Malhotra, seeking directions to cancel the remaining CBSE exams in view of the health risk of coronavirus infection. The apex court was also hearing a similar petition regarding the ICSE exams.

Indian Certificate of Secondary Education (ICSE), through its counsel Jaideep Gupta, also informed the court that it will also cancel the class 10 and 12 board exams. However, it submitted that it does not agree to give the option to students to give the exam later.

Bengaluru, May 27: Amidst helpless calls for learning to live with coronavirus and make a new beginning, the government of Karnataka is considering to reopen schools in the state from July 1.

Primary Education Minister S Suresh Kumar discussed the issue with the officials from the department at a meeting held on Tuesday. 

The expert committee in its report submitted to the Union Ministry for Human Resource Development recommended reopening of schools on July 1. The state department of primary and secondary education also discussed the issue. 

However, no decision has been taken yet and final decision is expected to out in a day or two. A source said that since the timetable for SSLC examination had been published and the lockdown was expected to be lifted after May 31, it had been planned to reopen the schools on July 1.

Following the recent representation by several academicians and social activists urging to cancel SSLC exams, the primary education minister met chief minister and briefed him about preparations for the safe conduct of exams.

“As of now there will not be any changes in SSLC exam schedule. We have reviewed the situation and preparations are underway for ensuring safety of children,” the source added. 

The report submitted by Nimhans about online education is yet to reach the secretariat.

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”